Blue Label Telecoms co-CEOs Mark and Brett Levy. JSE-listed Blue Label Telecoms is reaping financial benefit from its investment in Cell C, as its headline earnings per share (HEPS) shot up in the ...

The International Society for Stem Cell Research (ISSCR) released an update of its 2021 Guidelines for Stem Cell Research and Clinical Translation today. The targeted update addresses significant ...

Residents in Bokeelia are pushing back against a proposal to build a 150-foot cell tower on agricultural land, citing concerns about property values and preserving Pine Island's rural character. At ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Keith Berkle, chair of the ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...

Saha is senior vice president of government affairs for Premier Inc. McMullan is senior director of payment policy at Premier Inc. Today, more than 40% of adults over 60 are considered obese, fueling ...

In a new scientific paper published in nature, the Chinese manufacturer presented a new tandem perovskite-silicon solar cell based on a bottom cell with a heterojunction design. It also used a new ...

Polaris is undervalued due to short-term tariff and margin headwinds, offering a rare buying opportunity at a deeply discounted multiple. Disciplined cost control and strong brand power position ...

“Value-based care” (VBC) is one of the most frequently cited goals in U.S. healthcare reform — yet its meaning remains frustratingly vague and often contradictory. We hear that value-based care is the ...